Arbaclofen in fragile X syndrome: results of phase 3 trials

Title
Arbaclofen in fragile X syndrome: results of phase 3 trials
Authors
Keywords
Fragile X syndrome, Arbaclofen, GABA agonist, FMR1, Targeted treatment, Neurodevelopmental disorder
Journal
Publisher
Springer Nature
Online
2017-01-19
DOI
10.1186/s11689-016-9181-6

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now